Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1987-10-19
|
pubmed:language |
chi
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0578-1426
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
162-4, 190-1
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3622088-Adult,
pubmed-meshheading:3622088-Carrier State,
pubmed-meshheading:3622088-Drug Therapy, Combination,
pubmed-meshheading:3622088-Hepatitis B,
pubmed-meshheading:3622088-Humans,
pubmed-meshheading:3622088-Male,
pubmed-meshheading:3622088-Prednisone,
pubmed-meshheading:3622088-Vidarabine
|
pubmed:year |
1987
|
pubmed:articleTitle |
[Failure to treat chronic asymptomatic hepatitis B virus carriers with short-term prednisone and adenine-arabinoside].
|
pubmed:publicationType |
Journal Article,
English Abstract
|